Search
Filter Results
- Resource Type
- Article1
- Book1
- Book Digital1
- Exam Prep1
- Article Type
- Clinical Trial1
- Clinical Study1
- Controlled Clinical Trial1
- Result From
- Lane Catalog1
- PubMed1
-
Year
- Journal Title
- Obstet Gynecol1
Search Results
Sort by
- Book[edited by] Edgar V. Lerma, James M. Luther, Swapnil Hiremath.Contents:
Measurement of blood pressure in the office
Ambulatory and home blood pressure monitoring
Clinical evaluation of the patient with hypertension
Hypertensive emergencies and urgencies
The epidemiology of hypertension
Physiology of blood pressure regulation
Target organ damage or why should we treat hypertension?
Primary aldosteronism and mineralocorticoid hypertension
Glucocorticoid hypertension
Pheochromocytoma and paraganglioma
Other endocrine causes of hypertension
Renovascular hypertension
Drug-induced hypertension
Obstructive sleep apnea and hypertension
Hereditary causes of hypertension
Hypertension in children and adolescents
Hypertension in chronic kidney disease and end-stage kidney disease
Hypertension in diabetes
Hypertension after transplantation
Treatment of hypertension in obesity
Hypertension in blacks
Hypertension in the elderly
Hypertension in pregnancy
Hypertension in heart disease
Hypertension in stroke
Hypertension in the patient with aortic dissection
Resistant and pseudoresistant hypertension
Hyperkalemia in hypertension
Lifestyle modifications for hypertension management
Blood pressure treatment goals
Angiotensin-converting enzyme inhibitors and angiotensin receptor blocker
Calcium channel blockers
Direct vasodilators
Loop and thiazide diuretics
Potassium-sparing diuretics
Alpha antagonists
Beta-blockers
Alpha-agonists
Drug-drug and pharmacogenetic interactions
Role of device therapy
Orthostatic hypotension
Baroreflex dysfunction
Hypertension: origins.Digital Access ClinicalKey 2023 - ArticleKreutner AK, del Bene VE, Delamar D, Huguley V, Harmon PM, Mitchell KS.Obstet Gynecol. 1978 Sep;52(3):279-84.The effect of an 8-hour, 3-dose perioperative regimen of cefazolin or placebo was evaluated in 97 patients. Postoperative morbidity occurred in 13 patients (27.1%) in the cefazolin group and in 17 patients (34.7%) who received placebo. The clinical sites of infection were similar in both groups except that wound infections (2) and sepsis (2) were found only in patients receiving placebo. Aerobic organisms diminished and anaerobes increased in patients who received antibiotics. Aerobic isolates were essentially unchanged and fewer anaerobes were recovered from patients given placebo. Antibiotic levels observed at cesarean section were in the therapeutic range. The only risk factor which correlated with morbidity was the presence of ruptured membranes. This short course, single drug regimen did not significantly reduce morbidity although it was bacteriologically effective.